$60,000 of CORTEVA AGRISCIENCE lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"EPA regulatory issues pertaining to pesticides."
You can find more data on corporate lobbying on Quiver Quantitative.
CTVA Insider Trading Activity
CTVA insiders have traded $CTVA stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:
- ROBERT D. KING (EVP, Crop Protection Business) sold 37,280 shares for an estimated $2,765,993
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CTVA Hedge Fund Activity
We have seen 611 institutional investors add shares of CTVA stock to their portfolio, and 589 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 9,262,356 shares (+67.0%) to their portfolio in Q3 2025, for an estimated $626,413,136
- CAPITAL INTERNATIONAL INVESTORS removed 7,150,289 shares (-38.1%) from their portfolio in Q3 2025, for an estimated $483,574,045
- BLACKROCK, INC. added 6,379,354 shares (+12.7%) to their portfolio in Q3 2025, for an estimated $431,435,711
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 6,140,710 shares (-87.6%) from their portfolio in Q3 2025, for an estimated $415,296,217
- NUVEEN, LLC removed 5,716,253 shares (-73.6%) from their portfolio in Q3 2025, for an estimated $386,590,190
- BESSEMER GROUP INC removed 3,536,542 shares (-97.7%) from their portfolio in Q3 2025, for an estimated $239,176,335
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,331,876 shares (+78.0%) to their portfolio in Q3 2025, for an estimated $225,334,773
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CTVA Analyst Ratings
Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 10/30/2025
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- Argus Research issued a "Buy" rating on 10/13/2025
To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.
CTVA Price Targets
Multiple analysts have issued price targets for $CTVA recently. We have seen 8 analysts offer price targets for $CTVA in the last 6 months, with a median target of $79.0.
Here are some recent targets:
- Patrick Cunningham from Citigroup set a target price of $70.0 on 12/18/2025
- Richard Garchitorena from Wells Fargo set a target price of $77.0 on 11/11/2025
- Joshua Spector from UBS set a target price of $81.0 on 10/30/2025
- Alexandra Yates from Argus Research set a target price of $80.0 on 10/13/2025
- John Roberts from Mizuho set a target price of $78.0 on 10/08/2025
- Jeffrey Zekauskas from JP Morgan set a target price of $70.0 on 10/02/2025
- Benjamin Theurer from Barclays set a target price of $84.0 on 08/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
